Immunohistochemistry.
Immunohistochemistry for IL-6 in two high expressing cells. Top: stromal cell (S) expressing IL-6 (arrow); bottom: tumor cells (T) expressing IL-6 (arrow).
Inhibition of cell proliferation Cell proliferation assay analyzed the effect of siltuximab treatment on TFK1 and SZ1 cells, compared with control. Siltuximab reduced cell proliferation only on TFK1 cells but not on SZ1 cells.
Binding of antibody CABT-CS358 to antigen protein Immobilized human IL-6 His at 2 ug/mL can bind CABT-CS358, EC50=0.02278 ug/mL
Target
Alternative Names
IL6; Interleukin-6; BSF2; HSF; IFNB2
Entrez Gene ID
3569
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody. Learn More
Citations
Publication (2)
Have you cited CABT-CS358 in a publication? Let us know and earn a reward for your research.
Immunohistochemistry.
Immunohistochemistry for IL-6 in two high expressing cells. Top: stromal cell (S) expressing IL-6 (arrow); bottom: tumor cells (T) expressing IL-6 (arrow).
Inhibition of cell proliferation Cell proliferation assay analyzed the effect of siltuximab treatment on TFK1 and SZ1 cells, compared with control. Siltuximab reduced cell proliferation only on TFK1 cells but not on SZ1 cells.
Binding of antibody CABT-CS358 to antigen protein Immobilized human IL-6 His at 2 ug/mL can bind CABT-CS358, EC50=0.02278 ug/mL
My Review for Human Anti-Human IL6 (siltuximab biosimilar) Monoclonal antibody, clone siltuximab
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.